BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$9.69B |
| 2 |
Amazon
AMZN
|
+$3.39B |
| 3 |
Microsoft
MSFT
|
+$3.21B |
| 4 |
Walmart Inc
WMT
|
+$2.82B |
| 5 |
Nu Holdings
NU
|
+$2.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$1.61B |
| 2 |
Eli Lilly
LLY
|
+$1.36B |
| 3 |
WRK
WestRock Company
WRK
|
+$1.07B |
| 4 |
Comcast
CMCSA
|
+$733M |
| 5 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$710M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.14% |
| 2 | Financials | 12.2% |
| 3 | Healthcare | 11.99% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLDT
2501
Chatham Lodging
CLDT
$614M
| $46.5M | ﹤0.01% |
5,461,372
+297,812
| +6% | +$2.52M |
|
2502
Vanguard Total International Stock ETF
VXUS
$158B
| $46.2M | ﹤0.01% |
713,766
+171
| +0% | +$10.6K |
|
2503
Farmers National Banc Corp
FMNB
$946M
| $46.1M | ﹤0.01% |
3,049,129
+117,365
| +4% | +$1.7M |
|
2504
Olema Pharmaceuticals
OLMA
$985M
| $45.9M | ﹤0.01% |
3,847,471
-152,047
| -4% | -$1.94M |
|
2505
Alphatec Holdings
ATEC
$1.59B
| $45.9M | ﹤0.01% |
8,258,652
-33,772
| -0.4% | -$259K |
|
|
HONE
2506
DELISTED
HarborOne Bancorp
HONE
| $45.8M | ﹤0.01% |
3,531,642
+21,783
| +0.6% | +$272K |
|
2507
Sabesp
SBS
$19.1B
| $45.8M | ﹤0.01% |
14,276,570
+2,612,758
| +22% | +$8.34M |
|
|
CON
2508
Concentra Group Holdings
CON
$4.06B
| $45.7M | ﹤0.01% |
+2,044,640
| New | +$47.2M |
|
|
CBL
2509
CBL Properties
CBL
$1.81B
| $45.7M | ﹤0.01% |
1,813,047
-29,235
| -2% | -$742K |
|
|
KE
2510
Kimball Electronics
KE
$619M
| $45.6M | ﹤0.01% |
2,464,812
+23,144
| +0.9% | +$463K |
|
2511
ArriVent BioPharma
AVBP
$1.47B
| $45.4M | ﹤0.01% |
1,931,419
+1,268,154
| +191% | +$28.8M |
|
2512
Cass Information Systems
CASS
$722M
| $45.4M | ﹤0.01% |
1,093,723
+47,705
| +5% | +$1.97M |
|
|
SRDX
2513
DELISTED
Surmodics
SRDX
| $45.4M | ﹤0.01% |
1,169,670
-1,162
| -0.1% | -$47K |
|
|
MLNK
2514
DELISTED
MeridianLink
MLNK
| $45.3M | ﹤0.01% |
2,202,470
+241,981
| +12% | +$5.46M |
|
|
RVNC
2515
DELISTED
Revance Therapeutics, Inc.
RVNC
| $45.3M | ﹤0.01% |
8,727,584
+162,267
| +2% | +$806K |
|
2516
Annexon
ANNX
$860M
| $45.3M | ﹤0.01% |
7,647,714
+1,060,427
| +16% | +$6.29M |
|
2517
GeneDx Holdings
WGS
$2.01B
| $45.2M | ﹤0.01% |
1,066,202
+141,633
| +15% | +$4.78M |
|
2518
Rayonier Advanced Materials
RYAM
$608M
| $45.2M | ﹤0.01% |
5,276,082
+189,805
| +4% | +$1.32M |
|
2519
Health Catalyst
HCAT
$168M
| $45.1M | ﹤0.01% |
5,538,109
+105,400
| +2% | +$762K |
|
|
TRML
2520
DELISTED
Tourmaline Bio
TRML
| $45.1M | ﹤0.01% |
1,753,347
+29,131
| +2% | +$486K |
|
2521
Dianthus Therapeutics
DNTH
$6.04B
| $45M | ﹤0.01% |
1,644,819
+41,272
| +3% | +$1.15M |
|
2522
Liberty Live Group Series A
LLYVA
$9.12B
| $45M | ﹤0.01% |
908,910
-8,994
| -1% | -$351K |
|
2523
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
| $45M | ﹤0.01% |
886,001
| – | – |
|
2524
ARKO Corp
ARKO
$851M
| $44.9M | ﹤0.01% |
6,394,607
+125,706
| +2% | +$794K |
|
|
ALX
2525
Alexander's
ALX
$1.34B
| $44.8M | ﹤0.01% |
185,051
+6,718
| +4% | +$1.55M |
|
Similar funds
BlackRock's Q3 2024 Portfolio in Review
As of Q3 2024, BlackRock held 5,425 positions worth $4.76T, up 7.8% from $4.42T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
BlackRock's Q3 2024 filing shows 139 new, 3,002 increased, 1,518 reduced and 201 closed positions. Its largest new stake was Smurfit Westrock: 40,480,372 shares worth $2B. The largest sale was iShares MSCI EAFE ETF, an estimated $1.61B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q3 2024 buy was Smurfit Westrock: 40,480,372 shares worth $2B.
- BlackRock added most to Apple in Q3 2024, an estimated $9.69B increase.
- BlackRock's biggest Q3 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $1.61B.
- BlackRock fully exited WestRock Company in Q3 2024, selling an estimated $1.07B.
- BlackRock's ten largest holdings make up 26% of its $4.76T portfolio in Q3 2024.
- BlackRock opened 139 new positions and closed 201 in Q3 2024.
- BlackRock's portfolio value rose 7.8% quarter-over-quarter to $4.76T.
Based on BlackRock's 13F filing for Q3 2024, filed 13 Nov 2024.